✦ LIBER ✦

Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study

✍ Scribed by MOK, CHI CHIU; TONG, KA HANG; TO, CHI HUNG; SIU, YUI PONG; AU, TAK CHEUNG

Book ID: 109067267
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 83 KB
Volume: 68
Category: Article
ISSN: 0085-2538
DOI: 10.1111/j.1523-1755.2005.00461.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mizoribine intermittent pulse protocol f

Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients

✍ Hiroshi Tanaka; Koji Tsugawa; Eishin Oki; Koichi Suzuki; Etsuro Ito 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 103 KB

A comparative study of two intensified p

A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience

✍ Alaa Sabry; Hamdy Abo-Zenah; Tarek Medhat; Hussein Sheashaa; Khaled Mahmoud; Amr 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 207 KB

An open-label pilot study of the combina

An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction

✍ Siavash Dastjerdi, M; Kazemi, F; Najafian, A; Mohammady, M; Aminorroaya, A; Amin 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

Safety of long-term tacrolimus therapy f

Safety of long-term tacrolimus therapy for rheumatoid arthritis: an open-label, uncontrolled study in non-elderly patients

✍ Shinichi Kawai; Kortaro Tanaka; Iwao Ohno; Kazunori Utsunomiya; Yoshihiko Seino 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 361 KB

Remission of proliferative lupus nephrit

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: An open-label trial

✍ P. P. Sfikakis; J. N. Boletis; S. Lionaki; V. Vigklis; K. G. Fragiadaki; A. Inio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## Objective Autoreactive B cells play a key role in tissue injury in systemic autoimmune disease, and therefore a treatment resulting in B cell depletion could have benefit. This open‐label study was undertaken to evaluate the efficacy of the anti‐CD20 monoclonal antibody rituximab in

Nonimmersive Virtual Reality Mirror Visu

Nonimmersive Virtual Reality Mirror Visual Feedback Therapy and Its Application for the Treatment of Complex Regional Pain Syndrome: An Open-Label Pilot Study

✍ Kenji Sato; Satoshi Fukumori; Takashi Matsusaki; Tomoko Maruo; Shinichi Ishikawa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB